ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > IgG Isotype Controls

IgG Antibody Isotype Controls

IgG Isotype Controls
Introduction

Antibody drugs have become an important field in the development of biomedicine. Isotype control antibodies in antibody drug development are of the same class and subtype as the primary antibody developed against the target, but do not specifically bind to a known or potential target. The purpose of using the isotype control is to confirm that the binding or effect of the primary antibody is specific, excluding non-specific interactions with Fc receptor proteins or with other proteins. Meanwhile, isotype control can also be used as an antibody that competes for binding to Fc receptor proteins, which is related to functional blocking antibody perform the same function, which facilitates effective and reasonable evaluation of the efficacy of antibody drugs. Non-specific background is an important variable that needs to be controlled. Setting the corresponding isotype control antibody to detect non-specific binding can reduce the generation of false positive results and evaluate the possible influencing factors accurately in the drug development process.

We offer high-performance wild-type and mutant antibody isotype controls designed to accelerate your research. The wild-type Fc maintains its native conformation for reliable foundational studies and control experiments. And our mutant Fc is engineered with clinically relevant modifications that precisely match the engineering requirements of over 20 marketed therapeutic antibody. These rigorously validated isotype controls deliver exceptional specificity and reproducibility, with no endogenous background interference, ensuring trustworthy results across FACS, ELISA, and SPR applications. Whether you're conducting basic research or developing next-generation biologics, our isotype controls provide the critical standardization needed to advance your antibody discovery, validation, and therapeutic development workflows with confidence.

Product Features
Dual Fc Design - Flexible for Your Needs

Wild-type Fc: Preserves native conformation, ideal for high-confidence controls

Mutant Fc: Engineered to match 20+ approved therapeutic antibodies

High Reproducibility

Rigorous QC ensures batch-to-batch consistency

No endogenous background for reliable results

Ready-to-Use Multi-Tag System

Direct compatibility with major platforms (FACS/ELISA/SPR)

Product List
MoleculeCat. No.SpeciesProduct DescriptionPreorder/Order
Verification Data

High biological activity verified by ELISA

DNP-C11P1

Immobilized DNP-Albumin Conjugate, Bovine at 10 μg/mL (100 μL/well) can bind Human IgG1 (L234F,L235E,P331S) Kappa Isotype Control (mAb) (Cat. No. DNP-C11P1) with a linear range of 0.2-5 ng/mL (QC tested).

DNP-M884

Immobilized Dinitrophenyl-BSA Conjugate (DNP-BSA) at 10 μg/mL (100 μL/well) can bind Human IgG2 (A330S, P331S) Kappa Isotype Control (mAb) (Cat. No. DNP-M884) with a linear range of 0.05-2 ng/mL (QC tested).

DNP-M915

Immobilized DNP-Albumin Conjugate, Bovine at 10 μg/mL (100 μL/well) can bind Monoclonal Anti-DNP antibody, Human IgG3 Isotype Control (Cat. No. DNP-M915) with a linear range of 0.1-4 ng/mL (QC tested).

DNP-M886

Immobilized Dinitrophenyl-BSA Conjugate (DNP-BSA) at 10 μg/mL (100 μL/well) can bind Human IgG4 (S228P, L235E) Kappa Isotype Control (mAb) (Cat. No. DNP-M886) with a linear range of 0.02-2 ng/mL (QC tested).

FACS verified for use as isotype controls

DNP-M1A1-F1

2e5 of anti-CD19 CAR-293 cells were stained with 100ul of 1:50 dilution of 2e5 of anti-CD19 CAR-293 cells were stained with 100ul of 1:50 dilution of Mouse IgG1 kappa Isotype Control (Cat. No. DNP-M1A1) and positive control antibody respectively, washed and then followed by PE anti-mouse IgG1 and analyzed with FACS (QC tested).

DNP-BM190-F1

2e5 of anti-CD19 CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) Biotinylated Mouse IgG1 kappa Isotype Control (Cat. No. DNP-BM190) and positive control antibody (Cat. No. FM3-BY54) respectively, washed and then followed by PE-SA and analyzed with FACS (QC tested).

DNP-FM1A1-F1

2e5 of Anti-CD19 CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of FITC-Labeled Mouse IgG1 Isotype Control (Cat. No. DNP-FM1A1) and positive control (Cat. No. FM3-FY45P1) respectively, and FITC signal was used to evaluate the binding activity (QC tested).

DNP-PM1-F1

5e5 of Anti-CD19 CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of PE-Labeled Monoclonal Mouse IgG1 Isotype Control (Cat. No. DNP-PM1) and positive control (Cat. No. FM3-HPY53) respectively, and PE signal was used to evaluate the binding activity (QC tested).

Other Isotype Controls

IgG Fc Proteins——Ideal Isotype Control for IgG Structured Drug Development
ACRO Quality

This web search service is supported by Google Inc.

totopphone